Clinical trialNCT06493253CompletedObservational

Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)

SponsorPharmaNest, IncEnrollment1,519Metabolic Dysfunction-associated Steatotic Liver Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aim of this multi-center, retrospective epidemiologic study is to confirm the prognostic performance of the Digital Pathology (DP) FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS), derived from standard digital pathology liver biopsy images, in predicting clinical hepatic decompensation events in patients with metabolic dysfunction-associated steatohepatitis (MASH).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Arun J Sanyal, MD
Virginia Commonwealth University
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Cynthia Belhling, MD
University California San Diego
Study Director
clinicaltrials.gov ↗
David E Kleiner, MD. PhD
Nonalcoholic Steatohepatitis Clinical Research Network
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Virginia Commonwealth University
Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Sept 2025
Primary completion: 15 Mar 2026
Completion: 15 Mar 2026
Last update posted: 21 Aug 2026
Registered enrollment: 1,519
Registry id: NCT06493253

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.